Subjects

On this page readers can obtain a listing of documents under the subject headings. Click on the name of a subject heading to display the sub-headings, or to return to the main subjects. Click on the icon of a sub-heading to obtain the concerned documents. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding icon to open the publication. The PDF icon located on the cover page of a publication represents that the publication is available only in PDF format. If the PDF icon is located near the title of the publication it means the document is available in both HTML and PDF formats.
Expand the sub-collections menu.
560 documents on 12 pages
 
 
 
 
Open this document and view its content

70 Years of WHO Standards on Medicines Quality Expert Committee on Specifications for Pharmaceutical Preparations, 1947-2017: Addressing Changing Public Health Challenges. (WHO Drug Information Vol. 31, No. 1, 2017)

Year:

2017;

Pages:

12;


Regions:

 
Open this document and view its content

A70/23 - Dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/ faussement étiquetés/falsifiés/contrefaits. Rapport du Directeur général. Soixante-Dixième Assemblée mondiale de la Santé, 2017. (inclus : A70/23 Add.1 - Examen du dispositif des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits) (avec Appendice 1: Orientations pour l’élaboration d’un plan national en vue de prévenir, de détecter et de combattre les mesures, activités et comportements à l’origine de produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 2: Technologies d’authentification disponibles pour la prévention et la détection des produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits. Appendice 3: Dispositif OMS des États Membres concernant les produits médicaux de qualité inférieure/faux/faussement étiquetés/falsifiés/contrefaits: Définitions de travail) [Arabic] [Chinese] [English] [Russian] [Spanish]

Year:

2017;

Pages:

46;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación. Informe de la Directora General. La 70.ª Asamblea Mundial de la Salud, 2017. (incluido A70/23 Add.1 - Examen del mecanismo de Estados Miembros sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación) (con Apéndice 1: Orientaciones sobre la elaboración de un plan nacional para prevenir, detectar y contrarrestar las medidas, actividades y comportamientos que originan productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC). Apéndice 2: Tecnologías de autenticación disponibles para la prevención y la detección de productos médicos SSFFC. Apéndice 3: Mecanismo de estados miembros de la oms sobre productos médicos de calidad subestándar, espurios, de etiquetado engañoso, falsificados o de imitación (SSFFC): Definiciones funcionales) [Arabic] [Chinese] [English] [French] [Russian]

Year:

2017;

Pages:

44;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/ Counterfeit Medical Products. Report by the Director-general. Seventieth World Health Assembly, 2017. (With A70/23 Add.1 - Review of the Member State Mechanism On Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products) (with Appendix 1: Guidance on Developing a National Plan for Preventing, Detecting and Responding to Actions, Activities and Behaviours That Result in Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products. Appendix 2: Available Authentication Technologies for the Prevention and Detection of (Ssffc) Medical Products. Appendix 3: Who Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products: Working Definitions) [Arabic] [Chinese] [French] [Russian] [Spanish]

Year:

2017;

Pages:

42;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1 - Review of the Member State mechanism on substandard/spurious/falsely-labelled/ falsified/counterfeit medical products) (with Appendix 1: Guidance on developing a national plan for preventing, detecting and responding to actions, activities and behaviours that result in substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products. Appendix 2: Available authentication technologies for the prevention and detection of (SSFFC) medical products. Appendix 3: WHO member state mechanism on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products: Working definitions) (Arabic version) [Chinese] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

45;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Chinese version) A70/23 - 劣质、假造、标签不当、伪造、假冒 医疗产品问题会员国机制. 总干事的报告. 第七十届世界卫生大会, 2017. (A70/23 Add.1) (Chinese version) -关于劣质、假造、标签不当、伪造、假冒医疗产品问题会员国机制第五次会议的报告. 附录1 关于制定国家计划预防、发现和应对导致劣质、假造、标签不当、伪造、 假冒医疗产品的行动、活动和行为的指导. 附录2 预防和发现劣质、假造、标签不当、伪造、假冒医疗产品的现有认证技术. 附录3劣质、假造、标签不当、伪造、假冒医疗产品问题世卫组织会员国机制. 工作定义 [Arabic] [English] [French] [Russian] [Spanish]

Year:

2017;

Pages:

47;


Related documents:

Regions:

 
Open this document and view its content

A70/23 - Member State mechanism on substandard/spurious/falsely-labelled/falsified/ counterfeit medical products. Report by the Director-General. Seventieth World Health Assembly, 2017. (with A70/23 Add.1) (Russian version) A70/23 - МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/ КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ. ДОКЛАД ГЕНЕРАЛЬНОГО ДИРЕКТОРА. СЕМИДЕСЯТАЯ СЕССИЯ ВСЕМИРНОЙ АССАМБЛЕИ ЗДРАВООХРАНЕНИЯ, 2017. ВКЛЮЧЕНЫ (A70/23 Add.1) ДОБАВЛЕНИЕ 1 РУКОВОДСТВО ПО РАЗРАБОТКЕ НАЦИОНАЛЬНОГО ПЛАНА ПО ПРЕДОТВРАЩЕНИЮ, ВЫЯВЛЕНИЮ И ПРЕСЕЧЕНИЮ МЕР, ВИДОВ ДЕЯТЕЛЬНОСТИ И ФОРМ ПОВЕДЕНИЯ, КОТОРЫЕ ПРИВОДЯТ К СОЗДАНИЮ НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). ДОБАВЛЕНИЕ 2 ИМЕЮЩИЕСЯ ТЕХНОЛОГИИ АУТЕНТИФИКАЦИИ В ИНТЕРЕСАХ ПРЕДОТВРАЩЕНИЯ ПОЯВЛЕНИЯ НА РЫНКЕ И ВЫЯВЛЕНИЯ МЕДИЦИНСКОЙ ПРОДУКЦИИ НПЛФК ДОБАВЛЕНИЕ 3 МЕХАНИЗМ ГОСУДАРСТВ-ЧЛЕНОВ ВОЗ ПО НЕКОНДИЦИОННОЙ/ПОДДЕЛЬНОЙ/ЛОЖНО МАРКИРОВАННОЙ/ФАЛЬСИФИЦИРОВАННОЙ/КОНТРАФАКТНОЙ МЕДИЦИНСКОЙ ПРОДУКЦИИ (НПЛФК). РАБОЧИЕ ОПРЕДЕЛЕНИЯ [Arabic] [Chinese] [English] [French] [Spanish]

Year:

2017;

Pages:

54;


Related documents:

Regions:

 
Open this document and view its content

Addressing the Barriers to Effective Monitoring, Reporting and Containment of Spurious/Substandard/Falsely-labelled/ Falsified/Counterfeit Medical Products through Sustainable Multi-stakeholder Collaboration and Community/Consumer-based Interventions. A report prepared for the Medicines Transparency Alliance, Philippines

Year:

2016;

Pages:

94;


Related documents:

Countries:

 
Open this document and view its content

Analysis of the Regulatory Capacity to Assure the Quality of Antimalarial Medicines in Selected Countries of the Greater Mekong Subregion of Asia. March 2015

Year:

2015;

Pages:

110;


 
Open this document and view its content

Antimicrobial Resistance: What Does Medicine Quality Have to Do with It?

Year:

2015;

Pages:

45;

Regions:

 
Open this document and view its content

Assessment of the Regulatory Systems and Capacity of the Directorate General for Drug Administration in Bangladesh

Year:

2012;

Pages:

73;


Countries:

 
Open this document and view its content

Boas Práticas da OMS para Laboratórios de Controle de Qualidade de Produtos Farmacêuticos (Série de Relatórios Tecnicos da OMS, No. 957, 2010 - Relatório 44, Anexo 1) e Documento de Auto-Avaliação de Boas Práticas de Laboratório (BPL) - Rede PARF Documento Técnico No. 9 (Rede Pan-Americana da Harmonização de Regulamentação Farmacêutica) [English] [French] [Spanish] [Thai]

Year:

2011;

Pages:

58;


 
Open this document and view its content

Boas práticas da OMS para laboratórios de microbiologia farmacêutica - Rede PARF Documento Técnico Nº 11 (Rede Pan-Americana da Harmonização de Regulamentação Farmacêutica) [English]

Year:

2012;

Pages:

37;


 
Open this document and view its content

Building Clinical Trial Capacity to Develop a New Treatment for Multidrug-resistant Tuberculosis. (Bull World Health Organ 2016;94:147–152)

Year:

2016;

Pages:

6;


Regions:

 
Open this document and view its content

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

Year:

2007;

Pages:

4;

Regions:

 
Open this document and view its content

Clinical Trials Have Gone Global: Is This a Good Thing?

Year:

2012;

Pages:

5;

Related documents:

Regions:

 
 
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018